{"transactions":[{"id":1647498,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"exercise_date":"2023-11-21","expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647497,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F8","text":"Represents the modification of the option granted on November 21, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":0.59,"exercise_date":"2023-11-21","expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647496,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F7","text":"Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":12160,"derivative":{"exercise_price":1.6,"exercise_date":"2023-06-11","expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647495,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"security","element":"securityTitle","label":"F7","text":"Represents the modification of the option granted on June 11, 2023, resulting in (i) immediate vesting in full of the outstanding grant and (ii) extension of the exercise period until the expiration date in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":0,"derivative":{"exercise_price":1.6,"exercise_date":"2023-06-11","expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647494,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This restricted stock unit was granted on November 21, 2023 and pursuant to the issuance upon full vesting described in Footnote 2, is no longer outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647493,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"This restricted stock unit was granted on June 11, 2023 and pursuant to the issuance upon full vesting as described in Footnote 1, is no longer outstanding."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each restricted stock unit represents the right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647492,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on November 21, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":10920,"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1647491,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2024-02-13T15:08:40.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units granted on June 11, 2023, resulting from the full accelerated vesting in connection with Reporting Person's resignation from the Issuer's Board of Directors."}],"balance_after":5100,"source":{"system":"sec-edgar","filing":"0001493152-24-006050","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315224006050/ownership.xml","form_type":"4"}},{"id":1730569,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-11-24T16:00:13.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":6880,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":6880,"derivative":{"exercise_price":0.59,"expiration_date":"2033-11-21","underlying":"Common Stock","underlying_shares":6880},"source":{"system":"sec-edgar","filing":"0001493152-23-042665","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315223042665/ownership.xml","form_type":"4"}},{"id":1730568,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-11-24T16:00:13.000Z","date":"2023-11-21","kind":"grant","planned":false,"acquired":true,"shares":5820,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents supplemental grant issued to non-employee members of Board of Directors of Issuer, which includes 5,820 restricted stock units and 6,880 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan, as amended, and were approved by the Issuer's Compensation Committee."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A."}],"balance_after":5820,"derivative":{"underlying":"Common Stock","underlying_shares":5820},"source":{"system":"sec-edgar","filing":"0001493152-23-042665","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315223042665/ownership.xml","form_type":"4"}},{"id":1780595,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.01","published_at":"2023-09-15T17:15:30.000Z","date":"2023-09-14","kind":"sale","planned":false,"acquired":false,"shares":300,"price":0.64,"value":192.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects the weighted average sale price. The range of prices for such transaction was $0.6396 to $0.6507. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects the weighted average sale price. The range of prices for such transaction was $0.6396 to $0.6507. Open market sale transactions were made on the same day at different prices through a trade order executed by a broker-dealer. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001493152-23-032794","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315223032794/ownership.xml","form_type":"4"}},{"id":1857888,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock Options","published_at":"2023-06-13T18:44:16.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":12160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"security","element":"securityTitle","label":"F5","text":"Each option represents the right to purchase one share of common stock at the exercise price."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."}],"balance_after":12160,"derivative":{"exercise_price":1.6,"expiration_date":"2033-06-11","underlying":"Common Stock","underlying_shares":12160},"source":{"system":"sec-edgar","filing":"0001493152-23-021133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315223021133/ownership.xml","form_type":"4"}},{"id":1857887,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-13T18:44:16.000Z","date":"2023-06-11","kind":"grant","planned":false,"acquired":true,"shares":5100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents partial compensation for services as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 5,160 common stock purchase options as a discretionary grant."},{"field":"security","element":"securityTitle","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each restricted stock unit represents the right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The grants vest fully on the one (1) year anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"N/A"}],"balance_after":5100,"derivative":{"underlying":"Common Stock","underlying_shares":5100},"source":{"system":"sec-edgar","filing":"0001493152-23-021133","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000149315223021133/ownership.xml","form_type":"4"}},{"id":2405206,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-02-10T18:26:24.000Z","date":"2021-11-18","kind":"grant","acquired":true,"shares":48340,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares of Common Stock subject to the Option shall vest on each quarterly anniversary of the grant date over a one-year period."}],"balance_after":48340,"derivative":{"exercise_price":2.32,"expiration_date":"2032-11-17","underlying":"Common Stock","underlying_shares":48340},"source":{"system":"sec-edgar","filing":"0001209191-22-008586","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919122008586/doc4.xml","form_type":"4"}},{"id":2572563,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T18:40:55.000Z","date":"2021-09-10","kind":"purchase","acquired":true,"shares":2142,"price":2.98,"value":6383.16,"ownership":{"direct":true},"balance_after":14999,"source":{"system":"sec-edgar","filing":"0001209191-21-055729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121055729/doc4.xml","form_type":"4"}},{"id":2572562,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T18:40:55.000Z","date":"2021-09-09","kind":"purchase","acquired":true,"shares":3400,"price":2.89,"value":9826.0,"ownership":{"direct":true},"balance_after":12857,"source":{"system":"sec-edgar","filing":"0001209191-21-055729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121055729/doc4.xml","form_type":"4"}},{"id":2572561,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T18:40:55.000Z","date":"2021-09-08","kind":"purchase","acquired":true,"shares":5000,"price":2.75,"value":13750.0,"ownership":{"direct":true},"balance_after":9457,"source":{"system":"sec-edgar","filing":"0001209191-21-055729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121055729/doc4.xml","form_type":"4"}},{"id":2572560,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T18:40:55.000Z","date":"2021-09-07","kind":"purchase","acquired":true,"shares":2707,"price":2.78,"value":7525.46,"ownership":{"direct":true},"balance_after":4457,"source":{"system":"sec-edgar","filing":"0001209191-21-055729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121055729/doc4.xml","form_type":"4"}},{"id":2572559,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-13T18:40:55.000Z","date":"2021-08-31","kind":"purchase","acquired":true,"shares":1750,"price":2.75,"value":4812.5,"ownership":{"direct":true},"balance_after":1750,"source":{"system":"sec-edgar","filing":"0001209191-21-055729","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121055729/doc4.xml","form_type":"4"}},{"id":2736453,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":1223,"ownership":{"direct":false,"nature":"By Yuma Regional Medical Center"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F11","text":"Received in the Merger in exchange for a warrant to purchase 45,000 shares of LBS common stock for $0.73 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the President and Chief Executive Officer of Yuma Regional Medical Center and shares voting and investment power over the securities held by Yuma Regional Medical Center."}],"balance_after":1223,"derivative":{"exercise_price":26.85,"exercise_date":"2020-10-15","expiration_date":"2030-10-15","underlying":"Common Stock","underlying_shares":1223},"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}},{"id":2736452,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":13595,"ownership":{"direct":false,"nature":"By Yuma Regional Medical Center"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F10","text":"Received in the Merger in exchange for a warrant to purchase 500,000 shares of LBS common stock for $1.12 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the President and Chief Executive Officer of Yuma Regional Medical Center and shares voting and investment power over the securities held by Yuma Regional Medical Center."}],"balance_after":13595,"derivative":{"exercise_price":41.2,"exercise_date":"2019-08-15","expiration_date":"2029-08-15","underlying":"Common Stock","underlying_shares":13595},"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}},{"id":2736451,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":40785,"ownership":{"direct":false,"nature":"By Yuma Regional Medical Center"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"Received in the Merger in exchange for a warrant to purchase 1,500,000 shares of LBS common stock for $1.12 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the President and Chief Executive Officer of Yuma Regional Medical Center and shares voting and investment power over the securities held by Yuma Regional Medical Center."}],"balance_after":40785,"derivative":{"exercise_price":41.2,"exercise_date":"2019-03-08","expiration_date":"2029-03-08","underlying":"Common Stock","underlying_shares":40785},"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}},{"id":2736450,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":4406,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Received in the Merger in exchange for a stock option to acquire 162,069 shares of LBS common stock for $0.73 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option vests according to the following schedule: 25% of the shares underlying the option vests on the grant date and the remaining 75% vests in three equal quarterly installments thereafter beginning on September 30, 2020."}],"balance_after":4406,"derivative":{"exercise_price":26.85,"expiration_date":"2030-07-10","underlying":"Common Stock","underlying_shares":4406},"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}},{"id":2736449,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":1298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Received in the Merger in exchange for a stock option to acquire 47,758 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The stock option is fully vested."}],"balance_after":1298,"derivative":{"exercise_price":41.2,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":1298},"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}},{"id":2736448,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":10182,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Received in the Merger in exchange for a stock option to acquire 374,500 shares of LBS common stock for $1.12 per share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vested according to the following schedule: 25% of the shares underlying the option vested on the grant date and the remaining 75% vested in three equal quarterly installments thereafter beginning on June 30, 2019."}],"balance_after":10182,"derivative":{"exercise_price":41.2,"expiration_date":"2029-04-25","underlying":"Common Stock","underlying_shares":10182},"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}},{"id":2736447,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":94392,"kind":"person","name":"Trenschel Robert J.","position":1,"cik":"0001849917","reported_name":"Trenschel Robert J.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-29T17:55:15.000Z","date":"2021-04-27","kind":"grant","acquired":true,"shares":304479,"ownership":{"direct":false,"nature":"By Yuma Regional Medical Center"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in exchange for 11,198,208 shares of common stock of Leading BioSciences, Inc. (\"LBS\"), pursuant to the Agreement and Plan of Merger, dated December 16, 2020, among Seneca Biopharma Inc., Townsgate Acquisition Sub 1, Inc. and LBS (the \"Merger\").  Per the terms of the Merger, each share of LBS's common stock was converted into the right to receive 0.02719 shares of Seneca's common stock.  In the Merger, the name of the Issuer was changed from Seneca Biopharma, Inc. to Palisade Bio, Inc."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The Reporting Person is the President and Chief Executive Officer of Yuma Regional Medical Center and shares voting and investment power over the securities held by Yuma Regional Medical Center."}],"balance_after":304479,"source":{"system":"sec-edgar","filing":"0001209191-21-029080","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1849917/000120919121029080/doc4.xml","form_type":"4"}}]}